中文 | English
Return
Total: 69 , 1/7
Show Home Prev Next End page: GO
MeSH:(Antiviral Agents/pharmacology/*therapeutic use)

2.Antiviral therapy for "difficult-to-treat" hepatitis C virus-infected patients.

Tatsuo KANDA ; Osamu YOKOSUKA ; Masao OMATA

Chinese Medical Journal 2013;126(23):4568-4574

4.Traditional Uses, Phytochemistry, Pharmacology and Toxicology of Rhizoma phragmitis: A Narrative Review.

Yuan REN ; Ge-Dan CUI ; Li-Sha HE ; Huan YAO ; Chang-Yan ZI ; Yong-Xiang GAO

Chinese journal of integrative medicine 2022;28(12):1127-1136

5.Progress of research on Inonotus obliquus.

Xiu-hong ZHONG ; Kuang REN ; Shi-jie LU ; Shu-yan YANG ; Dong-zhi SUN

Chinese journal of integrative medicine 2009;15(2):156-160

6.Pharmacologic treatment of SARS: current knowledge and recommendations.

Dessmon Y H TAI

Annals of the Academy of Medicine, Singapore 2007;36(6):438-443

7.Research progress of neuraminidase inhibitors for anti-influenza.

Ai-Lin LIU ; Hai-Di WANG ; Fan YANG ; Guan-Hua DU

Acta Pharmaceutica Sinica 2009;44(9):935-942

8.Lamivudine-resistant analysis and management for chronic hepatitis B patients with initial lamivudine therapy.

Hui XU ; Yang CHEN ; Ling-Li HE ; Bing-Jun LEI ; Xue-Zhong LEI

Chinese Journal of Hepatology 2011;19(6):427-430

9.In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.

Rajib HOSSAIN ; Chandan SARKAR ; Shardar Mohammad Hafiz HASSAN ; Rasel Ahmed KHAN ; Mohammad ARMAN ; Pranta RAY ; Muhammad Torequl ISLAM ; Sevgi Durna DAŞTAN ; Javad SHARIFI-RAD ; Zainab M ALMARHOON ; Miquel MARTORELL ; William N SETZER ; Daniela CALINA

Chinese journal of integrative medicine 2022;28(3):249-256

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 69 , 1/7 Show Home Prev Next End page: GO